The declaration from Chinese pharma leaders gathered in the Beijing Yizhuang Economic Development Zone is a committment to develop and produce more biotech drugs that are affordable and safe for patients in China, to solve the problem of expensive drugs for Chinese patients and to help building „healthy China 2030“.
China Bio news release, October 31, 2016